FMI Forecasts Urinary Tract Infection Testing Industry to Hit US$1.1 Billion by 2033 with a 6.0% CAGR

Urinary Tract Infection Testing Industry
Urinary Tract Infection Testing Industry

The 2022 valuation of the worldwide urinary tract infection testing industry stood at an impressive US$ 563.0 Million, with a projected surge to reach US$ 1.1 Billion by 2033. Leading the charge in the testing category, urinalysis tests secured a dominant 48.5% share of the market’s value in 2022. This category is poised for robust growth, expected to maintain a close-to-6.0% compound annual growth rate (CAGR) throughout the forecast period spanning from 2023 to 2033.

According to the Centers for Disease Control and Prevention urinary tract infection surveillance report 2018, an estimated 93,300 morbidity cases were observed in acute care hospitals. Recurrent urinary tract infection is a major health issue in females across the globe.

According to the European Association of Urology, there is an increase in bacterial resistance to antibiotics in the region which leads to more research and development for novel therapeutics. With the latest upcoming techniques, the urinary tract infection testing industry will fuel the growth of the market.

Request a Sample Copy of the Report Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-10134

Urinary Tract Infection Testing: Market Dynamics

Urinary tract infection is expected to register significant growth in the market owing to the rising prevalence of urinary tract infections globally. The increasing geriatric population is another factor that is expected to boost the demand for urinary tract infection testing as the elderly population is at a high risk of contracting the same.

Moreover, patients who use urinary catheters are more likely to contract complicated urinary tract infections. This adds another factor that will spur the growth of the urinary tract infection testing market. Apart from this, manufacturers are currently focusing on developing new imaging techniques for urinary tract infection testing which may drive the growth of the urinary tract infection testing industry.

However, stringent and complex regulatory approvals for new launch of equipment and lack of government funding for research and development in developing countries may restrain the growth of the market.

Urinary Tract Infection Testing Industry: Overview

There has been an increase in the number of urinary tract infection patients across the globe. Urinary tract infection contributes to the second-largest patient pool in the world. Increasing prevalence and demand for better treatment option is likely to foster the growth of the market. The launch of new testing kits and devices will accelerate the growth of the urinary infection testing market.

For instance, in June 2019, MiDOG, LLC announced the launch of a new collection of urine kit and test for the diagnosis of fungal and bacterial pathogens in urinary tract infections of canine. With the launch of new technologies and an increase in several urinary tract infection testing kits and device players, urinary tract infection testing will spur the growth of the market.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-10134

Urinary Tract Infection Testing: Region-wise Outlook

Based on geography, the global urinary tract infection testing market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan and the Middle East & Africa.

North America is expected to anticipate substantial revenue generation in the urinary tract infection testing industry owing to advancements in research and development and, an increase in the launch of new urinary tract infection testing devices and instruments.

Europe also shares significant revenue generation in the urinary tract infection testing market owing to the increase in the adoption of new technologies and improved healthcare infrastructure. Asia Pacific has significant potential to stimulate the growth of the urinary tract infection testing industry due to the increasing prevalence of urinary tract infections and rising awareness about various bacterial infections.

Middle East and Africa have less impact on the urinary tract infection testing market due to poor healthcare infrastructure and less availability of diagnostic procedures which may hinder the growth of the urinary tract infection testing industry.

Urinary Tract Infection Testing Industry: Key Players

Some of the key players present across the value chain of the global urinary tract infection testing industry are Laboratory Corporation of America Holdings, Stryker, PENTAX Medical, Seimens Healthineers, Sysmex Corporation, Cardinal Health, Roche Diagnostics, Arkray Inc, Alere Inc., Streck, Quidel Corporation, Beckman Coulter, Bio-Rad Laboratories, DIRUI, ACON Laboratories, URIT Medical Electronic Ltd.

Urinary Tract Infection Testing Industry: Segmentation

 

Click Here to Buy Your Full Report
https://www.futuremarketinsights.com/checkout/10134

The global urinary tract infection testing Industry is segmented by test types and end-userr :

Urinary Tract Infection Segmentation by Test :

  • Laboratory Test
  • Urinalysis urinary tract infection testing
  • Urine culture urinary tract infection testing
  • Susceptibility of urinary tract infection testing
  • Non-laboratory Test
  • Kidney and bladder ultrasound urinary tract infection testing
  • Nuclear scans urinary tract infection testing
  • Cystoscopy urinary tract infection testing
  • Voiding cystourethrogram (VCUG) urinary tract infection testing

Urinary Tract Infection Segmentation by End User :

  • Hospitals
  • Diagnostics Laboratories
  • Research Institutes
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these